摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-溴-2-三氟甲氧基苯硼酸 | 1072951-56-4

中文名称
5-溴-2-三氟甲氧基苯硼酸
中文别名
5-溴-2-三氟甲氧基苯基硼酸
英文名称
(5-bromo-2-(trifluoromethoxy)phenyl)boronic acid
英文别名
5-Bromo-2-trifluoromethoxyphenylboronic acid;[5-bromo-2-(trifluoromethoxy)phenyl]boronic acid
5-溴-2-三氟甲氧基苯硼酸化学式
CAS
1072951-56-4
化学式
C7H5BBrF3O3
mdl
——
分子量
284.825
InChiKey
GLPYFDWQKJBUGP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    326.8±52.0 °C(Predicted)
  • 密度:
    1.79±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.03
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    49.7
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2931900090
  • 危险类别:
    IRRITANT
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302

SDS

SDS:b4edc1594edb5d6d32d57ccf65d47609
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Bromo-2-trifluoromethoxyphenylboronic acid
Synonyms: 5-Bromo-2-(trifluoromethoxy)phenylboronic acid

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-trifluoromethoxyphenylboronic acid
CAS number: 1072951-56-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5BBrF3O3
Molecular weight: 284.8

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    5-溴-2-三氟甲氧基苯硼酸哌啶potassium phosphatecopper(l) iodide四(三苯基膦)钯 、 dichloro[1,1'-bis(di-t-butylphosphino)ferrocene]palladium(II) 、 tris[tert-butyl]phosphonium tetrafluoroborate 作用下, 以 四氢呋喃1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 反应 53.0h, 生成 (R)-3-((3-(4-aminopyrido[3,2-d]pyrimidin-6-yl)-4-(trifluoromethoxy)phenyl)ethynyl)-3-hydroxy-1-methylpyrrolidin-2-one
    参考文献:
    名称:
    [EN] SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE
    [FR] INHIBITEURS À PETITE MOLÉCULE DE KINASE INDUISANT NF-KB
    摘要:
    本发明涉及抑制NIK的化合物,以及包含这些化合物的药物组合物和使用方法。这些化合物和药物组合物预期能用于预防或治疗癌症(如包括白血病、淋巴瘤和多发性骨髓瘤的B细胞恶性肿瘤)、炎症性疾病、自身免疫疾病、免疫皮肤病学疾病(如掌跖脓疱病和化脓性汗腺炎)以及代谢紊乱疾病(如肥胖和糖尿病)。
    公开号:
    WO2020239999A1
点击查看最新优质反应信息

文献信息

  • [EN] SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE<br/>[FR] INHIBITEURS À PETITE MOLÉCULE DE KINASE INDUISANT NF-KB
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2020239999A1
    公开(公告)日:2020-12-03
    The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.
    本发明涉及抑制NIK的化合物,以及包含这些化合物的药物组合物和使用方法。这些化合物和药物组合物预期能用于预防或治疗癌症(如包括白血病、淋巴瘤和多发性骨髓瘤的B细胞恶性肿瘤)、炎症性疾病、自身免疫疾病、免疫皮肤病学疾病(如掌跖脓疱病和化脓性汗腺炎)以及代谢紊乱疾病(如肥胖和糖尿病)。
查看更多